Chembio Diagnosticsincis A Global Leader In Point Of Care Diagnosticsfocusing On Rapid Tests For Infectious Diseasesbased In Hauppaugenew Yorkwith Additional Facilities In Medfordthe Company Develops Portable Diagnostic Solutions That Provide Results In About 15 Minutes Using A Small Drop Of Fingertip Bloodchembio S Patented Dual Path Platformdppa Technology Allows For The Simultaneous Detection Of Multiple Biomarkersimproving Accuracy For Conditions Such As Hivebolasyphiliszikamalariaand Febrile Illnesses The Company Offers Dpparapid Testswhich Are Clia Waived Assays Designed For Low Resource Settingsincluding Tests For Covid 19 And Sexually Transmitted Infectionschembio Also Provides Veterinary Diagnostics And Offers Manufacturing And Licensing Services For Its Dppatechnologyits Products Are Distributed Globallyserving Medical Laboratorieshospitalsgovernment Agenciesngosand Retailerswith A Mission To Enhance Disease Monitoring And Diagnosis Through Accessiblehigh Quality Diagnostics
